Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a new human pathogen in late 2019 and it has infected over 100 million people in less than a year. There is a clear need for effective antiviral drugs to complement current preventive measures, including vaccines. In this study,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, Arjan van Laarhoven, Pascal Miesen, Gerco den Hartog, Marien I. de Jonge, Ronald P. van Rij
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-02-01
Saila:	Viruses
Gaiak:	coronavirus COVID-19 antiviral compounds
Sarrera elektronikoa:	https://www.mdpi.com/1999-4915/13/2/282
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!